Home Newsfeeds Goldman Sachs Maintains Neutral on Element Solutions, Raises Price Target to $21

Goldman Sachs Maintains Neutral on Element Solutions, Raises Price Target to $21

Goldman Sachs analyst Duffy Fischer maintains Element Solutions (NYSE:ESI) with a Neutral and raises the price target from $19 to $21.

byBenzinga Newsdesk

December 15, 2022

1 minute read

Goldman Sachs analyst Duffy Fischer maintains Element Solutions (NYSE:ESI) with a Neutral and raises the price target from $19 to $21.

Aldeyra Therapeutics To Announce Top-Line Results From The Phase 3 INVIGORATE‑2 Trial In Allergic Conjunctivitis During Conference Call And Webcast On Thursday, June 15, 2023, At 8:00 a.m. ET

By Benzinga Newsdesk

June 14, 4:06 PM

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra) today announced it will host a webcast and conference call on Thursday, June 15, 2023, at 8:00 a.m. (ET) to provide top-line results from the Phase 3 INVIGORATE‑2 Trial

ALDX

B of A Securities Downgrades Angel Oak Mortgage to Underperform, Lowers Price Target to $6.5

By Benzinga Newsdesk

December 5, 8:27 AM

B of A Securities analyst Derek Hewett downgrades Angel Oak Mortgage (NYSE:AOMR) from Buy to Underperform and lowers the price target from $15.5 to $6.5.

AOMR

Tricon Sees FY23 Core FFO Per Share $0.55-$0.58; Narrows Same Home Revenue Growth From 6%-7% To 6%-6.5%

By Benzinga Newsdesk

November 7, 9:19 PM

2023 Guidance UpdateThe Company updated its guidance for the current fiscal year, including reiterating the midpoint of Core FFO per share guidance and tightening the range of expected same home metrics. The Company also

TCN

Detroit And New York’s Air Quality Plunge To Dangerous Levels Amid Canadian Wildfires

By AJ Fabino

June 7, 9:59 AM

Smoke from more than 413 active wildfires in Canada is causing poor air quality in North American cities,…

HON

Goldman Sachs Maintains Neutral on Element Solutions, Raises Price Target to $21

Related Posts

Aldeyra Therapeutics To Announce Top-Line Results From The Phase 3 INVIGORATE‑2 Trial In Allergic Conjunctivitis During Conference Call And Webcast On Thursday, June 15, 2023, At 8:00 a.m. ET

B of A Securities Downgrades Angel Oak Mortgage to Underperform, Lowers Price Target to $6.5

Tricon Sees FY23 Core FFO Per Share $0.55-$0.58; Narrows Same Home Revenue Growth From 6%-7% To 6%-6.5%

Detroit And New York’s Air Quality Plunge To Dangerous Levels Amid Canadian Wildfires